Boston Scientific Corporation has announced the close of its acquisition of Axonics, Inc., a medical technology company focused on the development and commercialisation of differentiated devices to treat urinary and bowel dysfunction.
“Over...
Boston Scientific (NYSE: BSX) announced today that it will purchase Ajax Health’s Cortex and its FDA-cleared OptiMap system to guide physicians performing ablation procedures to treat AFib
Financial terms of the deal were not disclosed. Boston Scientific expects to complete...
Boston Scientific Corporation has announced it has received U.S. Food and Drug Administration (FDA) approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal atrial fibrillation (AF) and FDA...
Cardiac implantable electronic devices have been a cornerstone in the management of arrhythmias for decades, but recent advancements are poised to reshape the landscape of cardiac care according to GlobalData, a...
Boston Scientific Corporation has announced it has obtained CE mark for the ACURATE Prime Aortic Valve System, the newest transcatheter aortic valve replacement (TAVR) technology in the company's structural heart portfolio.
The...
Bokf Na trimmed its stake in Boston Scientific Co. (NYSE:BSX – Free Report) by 13.9% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 2,688 shares of the...
Boston Scientific (NYSE:BSX – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, July 24th. Analysts expect the company to announce earnings of $0.58 per share...
Boston Scientific Corporation has obtained CE Mark on the Vercise Neural Navigator 5 Software with STIMVIEW XT technology, which when used as part of the Vercise Genus Deep Brain Stimulation (DBS) Systems, can...
The FDA announced today that it has designated a Boston Scientific recall of its Obsidio conformable embolic as Class I, its most serious level of recall.
The Obsidio embolic is a premixed embolic agent that is delivered in a minimally...
Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary...
